Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. حسب Hyung Suk Yang (20442438)

الموضوعات:

Transition probabilities and class sizes for three-step LTA model (N = 432). حسب Carolin Oetzmann (11397968)

الموضوعات:

Algorithm operation steps. حسب Junyan Wang (4738518)

الموضوعات:

Demonstration of test steps. حسب Jin Zhu (164147)

الموضوعات:

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. حسب Annaëlle Le Steunf (19838110)

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. حسب Hyung Suk Yang (20442438)

الموضوعات:

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. حسب Francesca Catto (21253435)

"…Additionally, the plots on the right side display the average plaque count across the cohorts. …"

Summary of five key points guiding the Safe Steps evaluation and implementation. حسب Esario IV Daguman (21474116)

الموضوعات:

The influence of the controlled pH conditions at the sample preparation step on the obtained signals (panel A: extraction using a mixture of MeOH and EtOH; panel B: extraction usin... حسب Ewa Paszkowska (21246702)

الموضوعات:

Schematic for preparation steps of BRA and recycled asphalt. حسب Ying Fang (147352)

الموضوعات:

Simulations show that microSLAM improves power and false positive rates. حسب Miriam Goldman (21433180)

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. حسب Claire M. Douglas (21238238)

الموضوعات:

Participant demographic and clinical characteristics. حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... حسب Claire M. Douglas (21238238)

الموضوعات:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... حسب Claire M. Douglas (21238238)

الموضوعات:

Schematic representation of the study protocol. حسب Neng Pan (5262032)

الموضوعات: